Literature DB >> 21160945

Liver-specific therapies for metastases of neuroendocrine pancreatic tumors.

Volker Fendrich1, Patrick Michl, Nils Habbe, Detlef Klaus Bartsch.   

Abstract

The presence or development of liver metastases in patients with neuroendocrine pancreatic tumors is the most important prognostic factor. Liver resection, transplantation and many different therapeutic approaches are discussed in this special review.

Entities:  

Keywords:  Biotherapy; Chemotherapy; Liver metastasis; Liver resection; Liver transplantation; Neuroendocrine pancreatic tumor

Year:  2010        PMID： 21160945      PMCID： PMC2998945          DOI： 10.4254/wjh.v2.i10.367

Source DB:  PubMed          Journal:  World J Hepatol


  47 in total

Review 1.  Hepatic surgery for metastatic gastrointestinal neuroendocrine tumors.

Authors:  Florencia G Que; Juan M Sarmiento; David M Nagorney
Journal:  Cancer Control       Date:  2002 Jan-Feb       Impact factor: 3.302

Review 2.  Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).

Authors:  U Plöckinger; G Rindi; R Arnold; B Eriksson; E P Krenning; W W de Herder; A Goede; M Caplin; K Oberg; J C Reubi; O Nilsson; G Delle Fave; P Ruszniewski; H Ahlman; B Wiedenmann
Journal:  Neuroendocrinology       Date:  2005-04-18       Impact factor: 4.914

3.  Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1.

Authors:  Detlef K Bartsch; Volker Fendrich; Peter Langer; Ilhan Celik; Peter H Kann; Matthias Rothmund
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

4.  Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors.

Authors:  Jens Rosenau; Matthias J Bahr; Reinhard von Wasielewski; Michael Mengel; Hartmut H J Schmidt; Björn Nashan; Hauke Lang; Jürgen Klempnauer; Michael P Manns; Klaus H W Boeker
Journal:  Transplantation       Date:  2002-02-15       Impact factor: 4.939

5.  Lethality of multiple endocrine neoplasia type I.

Authors:  G M Doherty; J A Olson; M M Frisella; T C Lairmore; S A Wells; J A Norton
Journal:  World J Surg       Date:  1998-06       Impact factor: 3.352

6.  Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups.

Authors:  Steven N Hochwald; Sui Zee; Kevin C Conlon; Roberto Colleoni; Otway Louie; Murray F Brennan; David S Klimstra
Journal:  J Clin Oncol       Date:  2002-06-01       Impact factor: 44.544

7.  Treatment of gastroenteropancreatic neuroendocrine tumours with octreotide LAR.

Authors:  P Tomassetti; M Migliori; R Corinaldesi; L Gullo
Journal:  Aliment Pharmacol Ther       Date:  2000-05       Impact factor: 8.171

8.  Large-volume liver metastases from neuroendocrine tumors: hepatic intraarterial 90Y-DOTA-lanreotide as effective palliative therapy.

Authors:  Mary K G McStay; Dave Maudgil; Martin Williams; Jonathan M Tibballs; Anthony F Watkinson; Martyn E Caplin; John R Buscombe
Journal:  Radiology       Date:  2005-09-28       Impact factor: 11.105

Review 9.  Surgical management of pancreatic endocrine tumors.

Authors:  Volker Fendrich; Jens Waldmann; Detlef K Bartsch; Peter Langer
Journal:  Nat Rev Clin Oncol       Date:  2009-06-09       Impact factor: 66.675

10.  Phase II study of thalidomide in patients with metastatic carcinoid and islet cell tumors.

Authors:  Kimberly A Varker; Jacqueline Campbell; Manisha H Shah
Journal:  Cancer Chemother Pharmacol       Date:  2007-06-23       Impact factor: 3.333
View more
  5 in total

1.  Predictors of response to radio-embolization (TheraSphere®) treatment of neuroendocrine liver metastasis.

Authors:  Mohammed Shaheen; Mazen Hassanain; Murad Aljiffry; Tatiana Cabrera; Prosanto Chaudhury; Eve Simoneau; Nuttawut Kongkaewpaisarn; Ayat Salman; Juan Rivera; Mohammad Jamal; Robert Lisbona; Azzam Khankan; David Valenti; Peter Metrakos
Journal:  HPB (Oxford)       Date:  2011-11-14       Impact factor: 3.647

2.  Neuroendocrine liver metastases: contributions of endoscopy and surgery to primary tumor search.

Authors:  Herwig Cerwenka
Journal:  World J Gastroenterol       Date:  2012-03-14       Impact factor: 5.742

3.  Surgical treatment of neuroendocrine liver metastases.

Authors:  Ser Yee Lee; Peng Chung Cheow; Jin Yao Teo; London L P J Ooi
Journal:  Int J Hepatol       Date:  2012-01-26

4.  Multimodal liver-directed management of neuroendocrine hepatic metastases.

Authors:  Mark A Lewis; Joleen Hubbard
Journal:  Int J Hepatol       Date:  2011-10-29

5.  ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes.

Authors:  Robert T Jensen; Guillaume Cadiot; Maria L Brandi; Wouter W de Herder; Gregory Kaltsas; Paul Komminoth; Jean-Yves Scoazec; Ramon Salazar; Alain Sauvanet; Reza Kianmanesh
Journal:  Neuroendocrinology       Date:  2012-02-15       Impact factor: 4.914
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.